Literature DB >> 17040966

Heart slice NMR.

Tadayuki Uetani1, Daisuke Yamashita, Juichiro Shimizu, Hiromi Misawa, Yasushi Tatematsu, Yukihisa Hamaguchi, Takehiro Miyasaka, Yuki Katanosaka, Toshiaki Kato, Tatsuaki Matsubara, Koichi Furukawa, Toyoaki Murohara, Miyako Takaki, Shinsuke Nakayama.   

Abstract

Nuclear magnetic resonance (NMR) spectroscopy of the heart is normally carried out using whole heart preparations under coronary perfusion. In such preparations, either radical changes in ionic composition of the perfusate or applications of numerous drugs would affect coronary microcirculation. This report communicates the first (31)P NMR spectroscopy study using a heart slice preparation (left ventricular slices) superfused with extracellular medium. The ratio of phosphocreatine concentration to ATP concentration was approximately 2.1. Also, intracellular pH and Mg(2+) concentration ([Mg(2+)](i)), estimated from the chemical shifts of inorganic phosphate and ATP, were comparable with those under retrograde perfusion. [Mg(2+)](i) was significantly increased by the removal of extracellular Na(+), supporting the essential role of Na(+)-coupled Mg(2+) transport in Mg(2+) homeostasis of the heart. Heart slice preparation could also be used to evaluate the potency of cardiac drugs, regardless of their possible effects on coronary microcirculation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17040966     DOI: 10.1152/ajpheart.00923.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  2 in total

1.  Triptolide improves systolic function and myocardial energy metabolism of diabetic cardiomyopathy in streptozotocin-induced diabetic rats.

Authors:  Zhongshu Liang; Sunnar Leo; Helin Wen; Mao Ouyang; Weihong Jiang; Kan Yang
Journal:  BMC Cardiovasc Disord       Date:  2015-05-13       Impact factor: 2.298

Review 2.  Myocardial Slices: an Intermediate Complexity Platform for Translational Cardiovascular Research.

Authors:  Samuel A Watson; Cesare M Terracciano; Filippo Perbellini
Journal:  Cardiovasc Drugs Ther       Date:  2019-04       Impact factor: 3.947

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.